Wikidata

(Q62110880)

English

Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
Treatment of Relapsed Acute Myelogenous Leukemia Consisting of Intermediate Dose Cytosine Arabinoside (ARA-C) Plus Interspaced Continuous Infusion Idarubicin, Followed by Continuous Infusion of Low-Dose ARA-C, A Phase II Study by the EORTC-LCG (English)
0 references
country
Belgium
0 references
Croatia
0 references
France
0 references
Italy
0 references
Netherlands
0 references
Portugal
0 references
Turkey
0 references
start time
December 1998
0 references
number of participants
60
0 references
research intervention
cytarabine
0 references
idarubicin
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62110880&oldid=2149433800"